CONTACT US
Search
Immunotherapy designed
to combat cancer

IDM Pharma is a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer.

We are currently developing two types of products designed to:

Destroy cancer cells by activating innate immunity
Prevent tumor recurrence by triggering a specific adaptive immune response

learn more >>

 
Latest News

07/01/2008

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)

06/02/2008

IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients

06/02/2008

IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE)
 

News Archive >>